Anti-DDB2 antibody [EPR9811]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal DDB2 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 14 publications.
View Alternative Names
DNA damage-binding protein 2, DDB p48 subunit, Damage-specific DNA-binding protein 2, UV-damaged DNA-binding protein 2, DDBb, UV-DDB 2, DDB2
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DDB2 antibody [EPR9811] (AB181136)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human stomach carcinoma tissue sections labeling DDB2 with Purified ab181136 at 1/2500 dilution (0.25 µg/mL). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- WB
Unknown
Western blot - Anti-DDB2 antibody [EPR9811] (AB181136)
40kDa band might be an isomer of DNA damage-binding protein 2 (Isomer D3).
All lanes:
Western blot - Anti-DDB2 antibody [EPR9811] (ab181136) at 1/2000 dilution
Lane 1:
SH-SY5Y (Human neuroblastoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 48 kDa
false
- WB
Supplier Data
Western blot - Anti-DDB2 antibody [EPR9811] (AB181136)
40kDa band might be an isomer of DNA damage-binding protein 2 (Isomer D3).
All lanes:
Western blot - Anti-DDB2 antibody [EPR9811] (ab181136) at 1/1000 dilution
All lanes:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 48 kDa
false
- WB
Unknown
Western blot - Anti-DDB2 antibody [EPR9811] (AB181136)
Lanes 1-3 : Merged signal (red and green). Green - ab181136 observed at 48 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab181136 Anti-DDB2 antibody [EPR9811] was shown to specifically react with DDB2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265115 (knockout cell lysate ab257177) was used. Wild-type and DDB2 knockout samples were subjected to SDS-PAGE. ab181136 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-DDB2 antibody [EPR9811] (ab181136) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
DDB2 knockout HeLa cell lysate at 20 µg
Lane 3:
Raji cell lysate at 20 µg
Predicted band size: 48 kDa
Observed band size: 48 kDa
false
- WB
Lab
Western blot - Anti-DDB2 antibody [EPR9811] (AB181136)
Lanes 1-3 : Merged signal (red and green). Green - ab181136 observed at 48 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab181136 Anti-DDB2 antibody [EPR9811] was shown to specifically react with DDB2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265115 (knockout cell lysate ab257177) was used. Wild-type and DDB2 knockout samples were subjected to SDS-PAGE. ab181136 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-DDB2 antibody [EPR9811] (ab181136) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
DDB2 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human DDB2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-ddb2-knockout-hela-cell-line-ab265115'>ab265115</a>)
Lane 3:
Raji cell lysate at 20 µg
Predicted band size: 48 kDa
Observed band size: 48 kDa
false
- WB
CiteAb
Western blot - Anti-DDB2 antibody [EPR9811] (AB181136)
DDB2 western blot using anti-DDB2 antibody [EPR9811] ab181136. Publication image and figure legend from Kumar, N., Theil, A. F., et al., 2022, Nat Commun, PubMed 35190564.
ab181136 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab181136 please see the product overview.
DDB2 binds sparse telomeric 8-oxoG independently of the DDB1-Cul4A-RBX1 E3 ligase.a Representative images showing recruitment of DDB2-mCherry to telomeric 8-oxoG in cells transfected with control, DDB1 or Cul4A siRNA. b Quantification of a. c, e DDB2-mCherry and GFP-DDB1 (c) or DDB2-mCherry and GFP-Cul4A (e) accumulation at 8-oxoG sites after dye (100 nM, 15 min) plus light (660 nm, 10 min) treatment. d, f Quantification of c and e respectively. g Western blot for DDB2 in U2OS-FAP-TRF1 cells treated with UVC, potassium bromate (KBrO3) or dye plus light at indicated doses. Independent experiments are represented by black circles. h Colocalization of DDB2-mCherry and GFP-Cul4A at damaged telomeres in U2OS-FAP-TRF1 cells transfected with control or OGG1 siRNA. i Quantification of h. Data (a–h) represents mean ± SEM from two independent experiments. 'n' represents the number of cells scored for each condition. One-way ANOVA (Sidak multiple comparison test) (b, i) was performed for statistical analysis : *p < 0.05, **p < 0.01, ***p < 0.001, ns Not significant. Scale : 5 μm. Source data are provided as a Source Data file. (See also Supplementary Fig. 5).
false
Related conjugates and formulations (2)
-
HRP Anti-DDB2 antibody [EPR9811]
-
Anti-DDB2 antibody [EPR9811] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Engagement in DNA repair mechanisms allows DDB2 to help maintain genomic stability. It forms a critical part of the DDB1-DDB2 complex which collaborates with other proteins in the initial damage recognition step of NER. This involvement ensures the repair of UV-induced damage and bulky DNA adducts preventing mutations that can cause harmful genetic alterations.
Pathways
The involvement of DDB2 is important within the nucleotide excision repair and transcription-coupled repair pathways. In these pathways DDB2 partners with proteins such as XPC and XPA facilitating the recognition and verification of DNA damage. These interactions ensure an accurate and efficient repair process protecting cells from potential genotoxic stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Molecular cell 84:4774-4789.e9 PubMed39591967
2024
Applications
Unspecified application
Species
Unspecified reactive species
NAR cancer 5:zcad057 PubMed38058548
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental hematology & oncology 12:77 PubMed37679762
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:4881-4898 PubMed36971122
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:e39 PubMed36861323
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:1052163 PubMed36568213
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:350 PubMed35428778
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:974 PubMed35190564
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 77:1092-1106.e9 PubMed31973889
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 27:984-998 PubMed31367012
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com